Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Bai R"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 66
Tytuł:
Outcome of catheter ablation for paroxysmal atrial fibrillation in patients with stable coronary artery disease.
Autorzy:
Cui YK; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hu R; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
He L; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Long DY; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yu RH; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sang CH; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang CX; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li SN; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wang W; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guo XY; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao X; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zuo S; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tang RB; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma CS; Department of Cardiology, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2022 Sep; Vol. 45 (9), pp. 1032-1041. Date of Electronic Publication: 2022 Aug 09.
Typ publikacji:
Journal Article
MeSH Terms:
Atrial Fibrillation*
Catheter Ablation*/adverse effects
Coronary Artery Disease*/complications
Coronary Artery Disease*/surgery
Hydroxymethylglutaryl-CoA Reductase Inhibitors*
Thromboembolism*/epidemiology
Thromboembolism*/etiology
Female ; Humans ; Recurrence ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Sex Differences and Temporal Trends in Hospitalization for Catheter Ablation of Nonvalvular Atrial Fibrillation: A Single-Center Experience for 15 Years.
Autorzy:
Peng X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Li L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Zhang M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Zhao Q; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Wu K; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Ruan Y; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Ma C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Pokaż więcej
Źródło:
Journal of interventional cardiology [J Interv Cardiol] 2022 Jul 04; Vol. 2022, pp. 6522261. Date of Electronic Publication: 2022 Jul 04 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/epidemiology
Atrial Fibrillation*/surgery
Catheter Ablation*
Child, Preschool ; Female ; Hospitalization ; Humans ; Male ; Retrospective Studies ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lambl's excrescence and the safety of radiofrequency ablation for atrial fibrillation.
Autorzy:
Zuo S; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bo X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
He L; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dai T; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Cui J; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wu J; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li S; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tang R; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sang C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Long D; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dong J; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2022 Jul; Vol. 45 (7), pp. 821-825. Date of Electronic Publication: 2022 Jun 13.
Typ publikacji:
Journal Article
MeSH Terms:
Atrial Fibrillation*/complications
Atrial Fibrillation*/surgery
Catheter Ablation*/methods
Heart Valve Diseases*/surgery
Aged ; Aortic Valve/surgery ; Echocardiography, Transesophageal ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
A strategy of idarucizumab for pericardial tamponade during perioperative period of atrial fibrillation ablation.
Autorzy:
Zhao X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Chen LZ; Department of Cardiology, Capital Medical University Affiliated Beijing Friendship Hospital.
Su X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; Department of Cardiology, The First Affiliated Hospital of Zhengzhou University.
Long DY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sang CH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yu RH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tang RB; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang CX; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guo XY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wang W; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2021 Nov; Vol. 44 (11), pp. 1824-1831. Date of Electronic Publication: 2021 Sep 28.
Typ publikacji:
Journal Article
MeSH Terms:
Catheter Ablation*
Antibodies, Monoclonal, Humanized/*administration & dosage
Atrial Fibrillation/*surgery
Cardiac Tamponade/*drug therapy
Cardiac Tamponade/*etiology
Aged ; Antithrombins/administration & dosage ; Dabigatran/administration & dosage ; Female ; Humans ; Male ; Middle Aged ; Perioperative Period ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effectiveness of ethanol infusion into the vein of Marshall combined with a fixed anatomical ablation strategy (the "upgraded 2C3L" approach) for catheter ablation of persistent atrial fibrillation.
Autorzy:
Lai Y; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sang C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Long D; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li M; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ge W; Department of Cardiology, Taizhou Hospital of Zhejiang Province, Taizhou, China.
Liu X; Department of Cardiology, Shengli Oilfield Central Hospital, Dongying, Shandong, China.
Lu Z; Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Guo Q; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; Department of Cardiology, Taizhou Hospital of Zhejiang Province, Taizhou, China.; Department of Cardiology, Shengli Oilfield Central Hospital, Dongying, Shandong, China.; Department of Cardiology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Jiang C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zuo S; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tang R; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guo X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li S; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wang W; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dong J; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2021 Jul; Vol. 32 (7), pp. 1849-1856. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/surgery
Catheter Ablation*/adverse effects
Pulmonary Veins*/surgery
Ethanol/adverse effects ; Humans ; Recurrence ; Tachycardia ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Ethanol infusion into the vein of Marshall for recurrent perimitral atrial tachycardia after catheter ablation for persistent atrial fibrillation.
Autorzy:
Sang C; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Lai Y; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Long D; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Li M; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Jiang C; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Wang W; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Li S; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Tang R; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Guo X; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Zhao X; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Zuo S; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Wen S; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Ning M; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Wu J; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Dong J; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Ma C; Department of Cardiology, Beijing Anzhen Hospital; National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2021 May; Vol. 44 (5), pp. 773-781. Date of Electronic Publication: 2020 Sep 08.
Typ publikacji:
Journal Article
MeSH Terms:
Catheter Ablation*
Atrial Fibrillation/*surgery
Ethanol/*administration & dosage
Tachycardia, Supraventricular/*drug therapy
Aged ; Coronary Angiography ; Epicardial Mapping ; Female ; Humans ; Infusions, Intravenous ; Male ; Middle Aged ; Recurrence ; Tachycardia, Supraventricular/physiopathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Effect of family history of atrial fibrillation on recurrence after atrial fibrillation ablation: A report from the Chinese Atrial Fibrillation Registry Study.
Autorzy:
Wu Z; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Jiang C; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Li J; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Du J; Beijing Centre for Disease Prevention and Control, China.
Bai Y; Faculty of Science, The University of Sydney, Sydney, Australia.
Guo X; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Wang W; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Li S; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Jiang C; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Liu N; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Tang R; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Bai R; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Sang C; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Long D; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Du X; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.; Heart Health Research Center, Beijing, China.; University of New South Wales, Sydney, Australia.
Ma C; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.
Dong J; Department of Cardiology, Beijing AnZhen Hospital, Capital Medical University, National Clinical Research Centre for Cardiovascular Diseases, Beijing Advanced Innovation Center for Big Data-Based Precision Medicine for Cardiovascular Diseases, Beijing, China.; Centre for Cardiovascular Diseases, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2021 Mar; Vol. 32 (3), pp. 678-685. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/epidemiology
Atrial Fibrillation*/genetics
Catheter Ablation*/adverse effects
Aged ; China/epidemiology ; Humans ; Middle Aged ; Recurrence ; Registries ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Catheter ablation of atrial fibrillation in situs inversus dextrocardia: Challenge, improved procedure, outcomes, and literature review.
Autorzy:
Zhao X; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Su X; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Long DY; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Sang CH; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Tang RB; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Jiang CX; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Li SN; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Guo XY; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Wang W; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Xin D; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Yu RH; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Chaoyang District, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2021 Feb; Vol. 44 (2), pp. 293-305. Date of Electronic Publication: 2021 Jan 05.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Abnormalities, Multiple*
Catheter Ablation*
Atrial Fibrillation/*complications
Atrial Fibrillation/*surgery
Dextrocardia/*complications
Situs Inversus/*complications
Aged ; Cardiac Surgical Procedures/methods ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Safety and efficacy of catheter ablation for atrial fibrillation in abdominal solid organ (renal and hepatic) transplant recipients: A single-center pilot experience.
Autorzy:
Su X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhao X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Long DY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sang CH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yu RH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tang RB; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang CX; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guo XY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wang W; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hu R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2020 Dec; Vol. 31 (12), pp. 3141-3149. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation*/diagnosis
Atrial Fibrillation*/drug therapy
Atrial Fibrillation*/surgery
Catheter Ablation*/adverse effects
Anti-Arrhythmia Agents/therapeutic use ; Humans ; Recurrence ; Transplant Recipients ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Physical activity and atrial tachyarrhythmia recurrence in atrial fibrillation patients after catheter ablation.
Autorzy:
Lu S; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.; Heart Health Research Center, Beijing, China.; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
Yang X; KLATASDS-MOE, School of Statistics, East China Normal University, Shanghai, China.
Jia Z; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Li J; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Xia S; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Chang S; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Zuo S; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Guo X; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Tang R; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Sang C; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Zhou Y; KLATASDS-MOE, School of Statistics, East China Normal University, Shanghai, China.
Dong J; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Ma C; Department of Cardiology, Beijing Anzhen Hospital, National Clinical Research Centre for Cardiovascular Diseases, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2020 Sep; Vol. 43 (9), pp. 922-929. Date of Electronic Publication: 2020 Aug 13.
Typ publikacji:
Journal Article
MeSH Terms:
Exercise*
Atrial Fibrillation/*surgery
Catheter Ablation/*methods
Tachycardia/*physiopathology
Aged ; China ; Female ; Humans ; Male ; Middle Aged ; Recurrence
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Effectiveness and safety of atrial fibrillation ablation in females.
Autorzy:
Li J; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sang C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.; Heart Health Research Center, Beijing, China.; The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia.
He L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Lu S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Xia S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Chang S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zuo S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Guo X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tang R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yu R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Long D; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Macle L; Department of Medicine, Montreal Heart Institute, Université de Montréal, Quebec, Canada.
Dong J; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma C; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2020 Jun; Vol. 43 (6), pp. 583-592. Date of Electronic Publication: 2020 May 25.
Typ publikacji:
Comparative Study; Journal Article; Multicenter Study
MeSH Terms:
Catheter Ablation*
Atrial Fibrillation/*surgery
Aged ; Cardiac Surgical Procedures/methods ; Female ; Humans ; Male ; Middle Aged ; Prospective Studies ; Sex Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Early versus delayed removal of the pericardial drain in patients with cardiac tamponade complicating radiofrequency ablation of atrial fibrillation.
Autorzy:
Zhao Q; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li L; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhang M; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wu K; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ruan Y; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dong J; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma C; Department of Cardiology, National Clinical Research Center for Cardiovascular Diseases, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2020 Mar; Vol. 31 (3), pp. 597-603. Date of Electronic Publication: 2020 Jan 10.
Typ publikacji:
Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Device Removal*/adverse effects
Atrial Fibrillation/*surgery
Cardiac Tamponade/*therapy
Catheter Ablation/*adverse effects
Drainage/*instrumentation
Pericardiocentesis/*instrumentation
Aged ; Cardiac Tamponade/diagnostic imaging ; Cardiac Tamponade/etiology ; Drainage/adverse effects ; Female ; Humans ; Male ; Middle Aged ; Pericardiocentesis/adverse effects ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Depolarization and repolarization parameters on ECG predict recurrence after atrial fibrillation ablation in patients with hypertrophic cardiomyopathy.
Autorzy:
Wen SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Zhu HJ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sun PY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Wu K; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ruan YF; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Tang RB; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Yu RH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Long DY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Sang CH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Jiang CX; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Li SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Hu R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Du X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2019 Nov; Vol. 30 (11), pp. 2405-2413. Date of Electronic Publication: 2019 Aug 31.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Action Potentials*
Electrocardiography*
Heart Rate*
Atrial Fibrillation/*surgery
Cardiomyopathy, Hypertrophic/*physiopathology
Catheter Ablation/*adverse effects
Adult ; Aged ; Atrial Fibrillation/complications ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/physiopathology ; Cardiomyopathy, Hypertrophic/complications ; Cardiomyopathy, Hypertrophic/diagnosis ; Female ; Humans ; Male ; Middle Aged ; Predictive Value of Tests ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Long-term outcome of catheter ablation for atrial fibrillation in patients with apical hypertrophic cardiomyopathy.
Autorzy:
Chen X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Du X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Wu JH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Yu RH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Long DY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Ning M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Sang CH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Jiang CX; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Wen SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Li SN; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Xu ZY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Tang RB; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2018 Jul; Vol. 29 (7), pp. 951-957. Date of Electronic Publication: 2018 Jun 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation/*diagnostic imaging
Atrial Fibrillation/*surgery
Cardiomyopathy, Hypertrophic/*diagnostic imaging
Cardiomyopathy, Hypertrophic/*surgery
Catheter Ablation/*trends
Aged ; Catheter Ablation/methods ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Catheter Ablation of Recurrent Paroxysmal Atrial Fibrillation: Is Gap-Closure Combining Ganglionated Plexi Ablation More Effective?
Autorzy:
Xu FQ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.; Department of Cardiology, The Affiliated Cardiovascular Hospital of Qingdao University, Qingdao, China.
Yu RH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Guo JJ; Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Liu N; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
An YI; Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, China.
Guo XY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Tang RB; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Long DY; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Sang CH; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
DU X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University and National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2017 Jun; Vol. 40 (6), pp. 672-682. Date of Electronic Publication: 2017 May 16.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Atrial Fibrillation/*epidemiology
Atrial Fibrillation/*surgery
Autonomic Denervation/*statistics & numerical data
Catheter Ablation/*methods
Ganglia, Autonomic/*surgery
Pulmonary Veins/*surgery
Atrial Fibrillation/diagnosis ; Catheter Ablation/statistics & numerical data ; China/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Prevalence ; Recurrence ; Retrospective Studies ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Prophylactic Atropine Administration Prevents Vasovagal Response Induced by Cryoballoon Ablation in Patients with Atrial Fibrillation.
Autorzy:
Sun L; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Dong JZ; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
DU X; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Bai R; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Li S; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Salim M; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Ma CS; Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.
Pokaż więcej
Źródło:
Pacing and clinical electrophysiology : PACE [Pacing Clin Electrophysiol] 2017 May; Vol. 40 (5), pp. 551-558. Date of Electronic Publication: 2017 Apr 25.
Typ publikacji:
Controlled Clinical Trial; Journal Article
MeSH Terms:
Atrial Fibrillation/*therapy
Atropine/*administration & dosage
Catheter Ablation/*adverse effects
Cryosurgery/*adverse effects
Premedication/*methods
Syncope, Vasovagal/*etiology
Syncope, Vasovagal/*prevention & control
Anti-Arrhythmia Agents ; Atrial Fibrillation/complications ; Female ; Humans ; Male ; Middle Aged ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Catheter Ablation for Atrial Fibrillation in Patients With Watchman Left Atrial Appendage Occlusion Device: Results from a Multicenter Registry.
Autorzy:
Turagam MK; Division of Cardiovascular Disease, University of Missouri Hospital and Clinics, Columbia, Missouri, USA.
Lavu M; Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA.
Afzal MR; Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA.
Vuddanda V; Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA.
Jazayeri MA; Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA.
Parikh V; Division of Cardiovascular Disease, University of Missouri Hospital and Clinics, Columbia, Missouri, USA.
Atkins D; Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA.
Bommana S; Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA.
DI Biase L; Montefiore Medical Center, Bronx, New York, USA.
Horton R; Texas Cardiac Arrhythmia Center, Austin, Texas, USA.
Bai R; Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Swarup V; Arizona Heart Rhythm Institute, Phoenix, Arizona, USA.
Cheng J; Texas Heart Institute, Houston, Texas, USA.
Natale A; Texas Cardiac Arrhythmia Center, Austin, Texas, USA.
Lakkireddy D; Division of Cardiovascular Diseases, Cardiovascular Research Institute, University of Kansas Hospital and Medical Center, Kansas City, Kansas, USA.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2017 Feb; Vol. 28 (2), pp. 139-146. Date of Electronic Publication: 2017 Jan 19.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Atrial Appendage*/diagnostic imaging
Atrial Appendage*/physiopathology
Catheter Ablation*/adverse effects
Septal Occluder Device*
Atrial Fibrillation/*surgery
Cardiac Catheterization/*instrumentation
Heart Septal Defects, Atrial/*therapy
Action Potentials ; Aged ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/physiopathology ; Cardiac Catheterization/adverse effects ; Echocardiography ; Electrophysiologic Techniques, Cardiac ; Feasibility Studies ; Female ; Heart Rate ; Heart Septal Defects, Atrial/diagnosis ; Heart Septal Defects, Atrial/physiopathology ; Humans ; Male ; Prosthesis Design ; Recurrence ; Registries ; Retrospective Studies ; Risk Factors ; Time Factors ; Treatment Outcome ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hybrid Procedure (Endo/Epicardial) versus Standard Manual Ablation in Patients Undergoing Ablation of Longstanding Persistent Atrial Fibrillation: Results from a Single Center.
Autorzy:
Edgerton Z; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Perini AP; Department of Heart and Vessels, University of Florence, Florence, Italy.
Horton R; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Trivedi C; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Santangeli P; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Hospital of the University of Pennsylvania, Pennsylvania, USA.
Bai R; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
Gianni C; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; University of Milan, Milan, Italy.
Mohanty S; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Burkhardt JD; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Gallinghouse GJ; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Sanchez JE; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Bailey S; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Lane M; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
DI Biase L; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; University of Foggia, Foggia, Italy.; Albert Einstein College of Medicine at Montefiore Hospital, New York, USA.
Santoro F; University of Foggia, Foggia, Italy.
Price J; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Natale A; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Department of Internal Medicine, Dell Medical School, Austin, Texas, USA.; California Pacific Medical Center, San Francisco, California, USA.; Interventional Electrophysiology, Scripps Clinic, San Diego, California, USA.; Division of Cardiology, Stanford University, Palo Alto, California, USA.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2016 May; Vol. 27 (5), pp. 524-30. Date of Electronic Publication: 2016 Feb 25.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Atrial Fibrillation/*surgery
Catheter Ablation/*methods
Endocardium/*surgery
Heart Atria/*surgery
Pericardium/*surgery
Action Potentials ; Aged ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Atrial Fibrillation/physiopathology ; Catheter Ablation/adverse effects ; Catheter Ablation/mortality ; Disease-Free Survival ; Endocardium/physiopathology ; Female ; Heart Atria/physiopathology ; Heart Rate ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Pericardium/physiopathology ; Postoperative Complications/etiology ; Recurrence ; Risk Factors ; Texas ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Management of Periprocedural and Early Pericardial Effusions With Tamponade Following Ablation of Atrial Fibrillation With Uninterrupted Factor Xa Inhibitors: A Case Series.
Autorzy:
Gianni C; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
DI Biase L; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.; Department of Biomedical Engineering, University of Texas, Austin, Texas, USA.; Department of Clinical and Experimental Medicine, University of Foggia, Foggia, Italy.
Mohanty S; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Trivedi C; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Bai R; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Al-Ahmad A; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Burkhardt JD; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Gallinghouse GJ; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Horton RP; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Department of Biomedical Engineering, University of Texas, Austin, Texas, USA.
Sanchez JE; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Hranitzky PM; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Lakkireddy D; Division of Cardiovascular Diseases, University of Kansas Medical Center, Kansas City, Kansas, USA.
Mansour MC; Division of Electrophysiology, Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts, USA.
Santangeli P; Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Zado ES; Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Marchlinski FE; Electrophysiology Section, Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Beheiry S; Electrophysiology and Arrhythmia Services, California Pacific Medical Center, San Francisco, California, USA.
Hao SC; Electrophysiology and Arrhythmia Services, California Pacific Medical Center, San Francisco, California, USA.
Couts L; Interventional Electrophysiology, Scripps Clinic, La Jolla, California, USA.
Gibson D; Interventional Electrophysiology, Scripps Clinic, La Jolla, California, USA.
Natale A; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.; Department of Biomedical Engineering, University of Texas, Austin, Texas, USA.; Electrophysiology and Arrhythmia Services, California Pacific Medical Center, San Francisco, California, USA.; Interventional Electrophysiology, Scripps Clinic, La Jolla, California, USA.; MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Division of Cardiology, Stanford University, Stanford, California, USA.; Dell Medical School, University of Texas, Austin, Texas, USA.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2016 Apr; Vol. 27 (4), pp. 399-403. Date of Electronic Publication: 2016 Feb 17.
Typ publikacji:
Case Reports; Journal Article; Multicenter Study
MeSH Terms:
Atrial Fibrillation/*surgery
Balloon Occlusion/*methods
Catheter Ablation/*adverse effects
Factor Xa Inhibitors/*administration & dosage
Pericardial Effusion/*prevention & control
Thromboembolism/*prevention & control
Aged ; Anticoagulants/administration & dosage ; Atrial Fibrillation/complications ; Cross-Sectional Studies ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Pericardial Effusion/etiology ; Postoperative Complications/prevention & control ; Premedication/methods ; Prognosis ; Thromboembolism/etiology ; Treatment Outcome ; United States
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pulmonary Vein Isolation to Reduce Future Risk of Atrial Fibrillation in Patients Undergoing Typical Flutter Ablation: Results from a Randomized Pilot Study (REDUCE AF).
Autorzy:
Mohanty S; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Natale A; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Department of Internal Medicine, Dell Medical School, Austin, Texas, USA.; California Pacific Medical Center, San Francisco, California, USA.
Mohanty P; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
DI Biase L; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.; Albert Einstein College of Medicine at Montefiore Hospital, New York, USA.
Trivedi C; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Santangeli P; University of Pennsylvania, Pennsylvania, USA.
Bai R; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Burkhardt JD; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Gallinghouse GJ; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Horton R; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Sanchez JE; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Hranitzky PM; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Al-Ahmad A; Univ Tor Vergata, Rome, Italy.
Hao S; California Pacific Medical Center, San Francisco, California, USA.
Hongo R; California Pacific Medical Center, San Francisco, California, USA.
Beheiry S; California Pacific Medical Center, San Francisco, California, USA.
Pelargonio G; Catholic University, Rome, Italy.
Forleo G; Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
Rossillo A; Ospedale dell' Angelo, Mestre /Venice, Italy.
Themistoclakis S; Ospedale dell' Angelo, Mestre /Venice, Italy.
Casella M; RCCS Monzino Hospital, Milan, Italy.
Russo AD; RCCS Monzino Hospital, Milan, Italy.
Tondo C; RCCS Monzino Hospital, Milan, Italy.
Dixit S; University of Pennsylvania, Pennsylvania, USA.
Pokaż więcej
Źródło:
Journal of cardiovascular electrophysiology [J Cardiovasc Electrophysiol] 2015 Aug; Vol. 26 (8), pp. 819-825. Date of Electronic Publication: 2015 May 26.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Atrial Fibrillation/*prevention & control
Atrial Flutter/*surgery
Catheter Ablation/*methods
Pulmonary Veins/*surgery
Action Potentials ; Aged ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/epidemiology ; Atrial Fibrillation/physiopathology ; Atrial Flutter/diagnosis ; Atrial Flutter/epidemiology ; Atrial Flutter/physiopathology ; Catheter Ablation/adverse effects ; Disease-Free Survival ; Electrocardiography, Ambulatory ; Female ; Heart Rate ; Humans ; Incidence ; Italy/epidemiology ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Pilot Projects ; Proportional Hazards Models ; Pulmonary Veins/physiopathology ; Risk Factors ; Telemetry ; Time Factors ; Treatment Outcome ; United States/epidemiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 66

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies